Vamifeport
Vamifeport (VIT-2763) is an oral ferroportin inhibitor that reduces hemolysis and improves anemia in SCD models. It also ameliorates vascular inflammation and dysregulated erythropoiesis, supporting its research in sickle cell disease and β-thalassemia using both in vivo and in vitro experimental systems.
Product Specifications
CAS Number
2095668-10-1
Product Name Alternative
Ferroptosis, VIT 2763, VIT2763, VIT-2763
Field of Research
Cell Biology, Pharmacology & Drug Discovery
Purity
99.26% (May vary between batches)
Solubility
DMSO:70 mg/mL (171.39 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.9 mM)
Smiles
Fc1cccnc1CNC (=O) c1coc (CCNCCc2nc3ccccc3[nH]2) n1
Molecular Formula
C21H21FN6O2
Molecular Weight
408.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog